Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2013;38(6):496-500.
doi: 10.1159/000357052. Epub 2013 Dec 11.

Cost analysis of an intravenous to subcutaneous epoetin α conversion

Lori D Wazny  1 , Colette B Raymond, Amy R Sood, Amanda Eng, Mauro Verrelli
Affiliations
Multicenter Study

Cost analysis of an intravenous to subcutaneous epoetin α conversion

Lori D Wazny et al. Am J Nephrol. 2013.

Abstract

Background/aims: A cost analysis of a conversion from intravenous (IV) to subcutaneous (SC) epoetin α in patients receiving chronic in-center hemodialysis (HD).

Methods: This retrospective analysis compared epoetin α drug costs during a 6-month period of IV usage (July to December 2010, period 1) to a 6-month period of SC usage (July to December 2011, period 2) in four large in-center HD units. Data were collected from quarterly counts of HD patients receiving epoetin α and monthly inventory billing records.

Results: 622 HD patients who received IV epoetin α (period 1) were compared to 609 HD patients who received SC epoetin α (period 2). A 12.6% decrease in dose was observed. The average weekly cost of epoetin α was USD 173.02 per patient during the IV period versus USD 151.20 per patient during the SC period. This equated to a yearly cost savings of USD 1,135 per patient with SC epoetin α.

Conclusion: The switch from IV to SC epoetin α was successfully implemented in all four centers and realized significant cost savings.

PubMed Disclaimer

Publication types